[Federal Register Volume 70, Number 9 (Thursday, January 13, 2005)]
[Notices]
[Page 2396]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-690]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Intent To Grant an Exclusive License of a U.S. Government-Owned 
Patent

AGENCY: Department of the Army, DoD.

ACTION:  Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 35 U.S.C. 209 and 37 CFR 404.7(a)(1)(i), 
announcement is made of the intent to grant an exclusive, royalty-
bearing, revocable license within the geographic area of the United 
States of America and its territories and possessions to U.S. 
Provisional Patent S.N. 60/533,375, filed December 24, 2003, entitled 
``Identification of Small Molecules of Inhibitors of Anthrax Factor,'' 
to Microbiotix, Inc. with its principal place of business at 1 
Innovation Drive, STE 15, Worcester, Massachusetts 01605-4332.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Anyone wishing to object to the grant of 
this license can file written objections along with supporting 
evidence, if any, within 15 days from the date of this publication. 
Written objections are to be filed with the Command Judge Advocate (see 
ADDRESSES).

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 05-690 Filed 1-12-05; 8:45 am]
BILLING CODE 3710-08-M